Communicate with Supplier? Supplier
Vicky Ms. Vicky
What can I do for you?
Chat Now
Chat Now Contact Supplier
Jinan Guoding Pharmaceutical Co.,Ltd
HomeNewsLarotrectinib (LOXO-101)Development Course Shows Promise for TRK Fusion–Positive Cancers

Larotrectinib (LOXO-101)Development Course Shows Promise for TRK Fusion–Positive Cancers


Looking at the pipeline for larotrectinib, it shows an accelerated course, which can be attributed to the drug`s potential to fulfill an unmet need in oncology.

Following larotrectinib`s discovery in 2013, in in vitro models, the agent demonstrated high potency against TRKA, TRKB, and TRKC, which are 3 TRK proteins that are encoded by NTRK1, NTRK2, and NTRK3.

In solid tumors, the agent was preclinically tested on a lung adenocarcinoma cell line harboring an MPRIPNTRK1 fusion, as well as a colorectal cancer cell line harboring a TPM3-NTRK1 fusion.Larotrectinib also had preclinical evaluation in hematologic malignancies in an acute myeloid leukemia cell line harboring an ETV6-NTRK3 fusion. Administration of larotrectinib in these cell lines led to a significant reduction in tumor growth. Responses to larotrectinib in these preclinical models occurred within 2 weeks of treatment initiation.1

Larotrectinib works by blocking the adenosine triphosphate binding site. The drug appears to have high binding affinity for all 3 TRK receptors.

We provide Larotrectinib Intermediates ,Entrectinib Intermediates,Praprofen Intermediates,TPX-0005 intermediates,Brigatinib Intermediates,AmenaMevir Intermediates,etc.

Jinan Guoding Pharmaceutical Co.,Ltd
Business Type:Manufacturer
Product Range:Custom Chemical Services , Organic Intermediate , Pharmaceutical
Products/Service:Praprofen Intermediates , Larotrectinib Intermediates , Entrectinib Intermediates , Repotrectinib Intermediates , Amenamevir Intermediates , Active Pharmaceutical Ingredient
Company Address:5F,Building G,Diya Shuangchuang Industrial Park,No.2566,Century Avenue,High-tech Zone,Jinan City,Shandong Province, Jinan, Shandong, China

Previous: Amenamevir, a novel helicase–primase inhibitor, for treatment of herpes zoster

Next: Application Of Betadex Sulfobutyl Ether Sodium In Praprofen Eye Drops

Related Products List




About Us